Jacques Passagot
About
In The Last Decade
Jacques Passagot
16 papers receiving 327 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 152
- Hepatology 132
- Molecular Biology 75
- Cardiology and Cardiovascular Medicine 61
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Jacques Passagot
This map shows the geographic impact of Jacques Passagot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Passagot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Passagot more than expected).
Fields of papers citing papers by Jacques Passagot
This network shows the impact of papers produced by Jacques Passagot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Passagot. The network helps show where Jacques Passagot may publish in the future.
Co-authorship network of co-authors of Jacques Passagot
This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Passagot. A scholar is included among the top collaborators of Jacques Passagot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Passagot. Jacques Passagot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | [Biochemical monitoring of prostate cancer treated exclusively by radiotherapy: prognostic value of pretreatment PSA, PSA nadir and PSA half-life]. | 3 |
| 3 | 42 | |
| 4 | 24 | |
| 5 | 2 | |
| 6 | 14 | |
| 7 | 64 | |
| 8 | 10 | |
| 9 | 4 | |
| 10 | 73 | |
| 11 | 22 | |
| 12 | 9 | |
| 13 | 32 | |
| 14 | 20 | |
| 15 | 10 | |
| 16 | [Adaptation to the cell line PLC/PRF/5 of hepatitis A virus released in the cell culture medium]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.